Le Lézard
Classified in: Science and technology
Subjects: AWD, SBS

Infinia ML Named Machine Learning "Hot Vendor" by HfS Research



DURHAM, N.C., July 17, 2018  /PRNewswire/ -- Infinia ML announced today that it had been named a Hot Vendor in the field of machine learning by HfS Research. The HfS report notes Infinia's "mission to link ML development to measurable business impact for its clients", its "distinguished leadership team", and its "dedication to research and innovation." According to HfS, Infinia ML's "experience, talent, and IP has earned it the HfS Hot Vendor tag."

The report highlights Infinia ML client projects in contract analysis, pay benchmarking, ultrasound image identification, cancer detection, and more. HfS says its Hot Vendors, chosen via a five-step assessment process, "display truly differentiated offerings and out-of-the-box thinking that can be both inspiring and useful."

HfS CEO and Chief Analyst Phil Fersht said the decision to name Infinia ML to the group was straightforward. "A lot of companies claim machine learning expertise but struggle to develop their talent in any relevant depth," he said. "Infinia ML backs up that claim with research credentials, real-world experience, and a record of business impact. The firm brings a fresh, no-nonsense approach to ML development and directs its clients away from conducting mere 'science experiments,' refocusing efforts around building business value?growing revenues and driving down costs."

Infinia CEO Robbie Allen celebrated the designation. "We're thrilled to be recognized as a Hot Vendor by HfS Research," he said. "We will strive to live up to the honor by helping clients leverage machine learning to redefine what's possible."

About Infinia ML

Infinia ML is a team of advanced machine learning experts helping enterprise clients reduce costs, increase efficiency, and achieve breakthroughs. Infinia ML serves industries from manufacturing and healthcare to marketing and human resources. The company's capabilities include natural language processing, recommendation engines, object detection, 3D image modeling, and anomaly detection. Together, the Infinia ML team has produced 31 patents, 11 books, 7 Ph.D.s, and more than 575 published papers. 

Learn more at InfiniaML.com.

About HfS Research

HfS provides visionary insight into the major innovations impacting business operations: automation, artificial intelligence, blockchain, digital business models and smart analytics. The company focuses on the future of operations across key industries. It influences the strategies of enterprise customers to develop operational backbones to stay competitive and partner with capable services providers, technology suppliers, and third-party advisors.

Media Contact:
James Kotecki
198648@email4pr.com
202-531-5884

SOURCE Infinia ML


These press releases may also interest you

at 12:20
Texas Instruments Incorporated (TI) Chairman, President and Chief Executive Officer Rich Templeton will speak at the 2018 Citi Global Technology Conference in New York City on Wednesday, September 5, at 10:20 a.m. Eastern time. Templeton will field...

at 12:15
The "Global Distributed Antenna Systems Market - Growth, Trend and Forecasts (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering. The Distributed Antenna Systems market is expected to witness a CAGR of 11%, over the forecast...

at 12:13
Taipei will host the world's first major music festival to run on blockchain technology -- more than 30,000 revelers at next month's Ultra Taiwan 2018 are to pay for goods and services in Ultra Coin on Pundi X technology....

at 12:06
Fundomate, a leading fintech company focusing on the alternative lending space, and IRIS CRM, a premier merchant services CRM servicing clients in the payment industry, today announced their integration which will enable mutual clients with the...

at 12:00
FixStream, a pioneer in solutions for Artificial Intelligence for IT operations (AIOps), and Cherwell Software, a global leader in enterprise service management, today announced a strategic collaboration designed to accelerate digital transformation....

at 12:00
Viela Bio announced today the start of the company's first clinical trial, a phase 1, first-in-human clinical trial of VIB9600, which is being developed for the treatment of adult patients with immune mediated diseases. Following the completion of...




News published on 17 july 2018 at 08:45 and distributed by: